Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.

Park DJ, Yoon C, Thomas N, Ku GY, Janjigian YY, Kelsen DP, Ilson DH, Goodman KA, Tang LH, Strong VE, Coit DG, Yoon SS.

Ann Surg Oncol. 2014 Apr;21(4):1130-7. doi: 10.1245/s10434-013-3429-0. Epub 2013 Dec 27.

PMID:
24370903
2.

Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.

Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT.

J Surg Oncol. 2013 Dec;108(8):542-9. doi: 10.1002/jso.23430. Epub 2013 Sep 9.

PMID:
24018956
3.

Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.

Zhang YF, Shi J, Yu HP, Feng AN, Fan XS, Lauwers GY, Mashimo H, Gold JS, Chen G, Huang Q.

World J Gastroenterol. 2012 Jul 21;18(27):3602-9. doi: 10.3748/wjg.v18.i27.3602.

4.

Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric Adenocarcinoma.

Park DJ, Seo AN, Yoon C, Ku GY, Coit DG, Strong VE, Suh YS, Lee HS, Yang HK, Kim HH, Yoon SS.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1508-15. doi: 10.1245/s10434-015-4790-y. Epub 2015 Aug 11.

5.

Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.

Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF.

Ann Surg Oncol. 2007 Feb;14(2):306-16. Epub 2006 Nov 8.

PMID:
17091329
6.

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.

Phillips BE, Tubbs RR, Rice TW, Rybicki LA, Plesec T, Rodriguez CP, Videtic GM, Saxton JP, Ives DI, Adelstein DJ.

Dis Esophagus. 2013 Apr;26(3):299-304. doi: 10.1111/j.1442-2050.2012.01369.x. Epub 2012 Jun 7.

PMID:
22676551
7.

Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.

Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, Coit DG.

Ann Surg Oncol. 2013 Feb;20(2):548-54. doi: 10.1245/s10434-012-2598-6. Epub 2012 Sep 1.

PMID:
22941159
8.

Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.

Yang LP, Fu LC, Guo H, Xie LX.

Onkologie. 2012;35(3):88-93. doi: 10.1159/000336807. Epub 2012 Feb 24.

PMID:
22414971
9.

Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.

Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.

Ann Surg Oncol. 2012 Feb;19(2):677-83. doi: 10.1245/s10434-011-1983-x. Epub 2011 Aug 6.

PMID:
21822549
10.

Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?

Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell B.

Ann Surg Oncol. 2016 Feb;23(2):626-32. doi: 10.1245/s10434-015-4898-0. Epub 2015 Nov 12.

PMID:
26564243
11.

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH.

BMC Cancer. 2010 May 14;10:203. doi: 10.1186/1471-2407-10-203.

12.

Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.

Aurello P, D'Angelo F, Nigri G, Bellagamba R, Cicchini C, Ruzzetti R, Ramacciato G.

Am Surg. 2006 Feb;72(2):118-23. Review.

PMID:
16536239
14.

Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer.

Villarejo-Campos P, Padilla-Valverde D, Martin RM, Menéndez-Sánchez P, Cubo-Cintas T, Bondia-Navarro JA, Fernández JM.

Clin Transl Oncol. 2013 Apr;15(4):265-70. doi: 10.1007/s12094-012-0908-x. Epub 2012 Jul 24.

PMID:
22855190
15.

[Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].

Pedrazzani C, Pasini F, Giacopuzzi S, Bernini M, Ruzzenente A, Festini M, Tomasi I, Cristadoro L, de Manzoni G.

G Chir. 2004 Oct;25(10):325-33. Italian.

PMID:
15756954
16.

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJ, Wijnhoven BP.

Ann Surg Oncol. 2012 Jul;19(7):2142-8. doi: 10.1245/s10434-012-2218-5. Epub 2012 Mar 7.

17.

A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal versus Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population.

Adeshuko FA, Squires MH, Poultsides G, Pawlik TM, Weber SM, Schmidt C, Votanopoulos K, Fields RC, Maithel SK, Cardona K.

Am Surg. 2017 Jan 1;83(1):82-89.

PMID:
28234131
18.
19.

Staging laparoscopy in gastroesophageal and gastric adenocarcinoma: first experience from Pakistan.

Bhatti AB, Haider S, Khattak S, Syed AA.

Indian J Cancer. 2014 Jan-Mar;51(1):15-7. doi: 10.4103/0019-509X.134603.

20.

[Clinical and pathological prognostic factors for cancers of the esophagogastric junction].

Schmidt SC, Schlechtweg N, Veltzke-Schlieker W, Thuss-Patience P, Pratschke J, Neuhaus P, Schumacher G.

Zentralbl Chir. 2009 Sep;134(5):455-61. doi: 10.1055/s-0029-1224512. Epub 2009 Sep 15. German.

PMID:
19757346

Supplemental Content

Support Center